Karli R Reiding Selected Research

Biomarkers (Surrogate Marker)

6/2023	Serum N-Glycomic Biomarkers Predict Treatment Escalation in Inflammatory Bowel Disease.
1/2021	Distinguishing Benign and Malignant Thyroid Nodules and Identifying Lymph Node Metastasis in Papillary Thyroid Cancer by Plasma N-Glycomics.
1/2018	Plasma N-Glycan Signatures Are Associated With Features of Inflammatory Bowel Diseases.
1/2017	Subclass-specific IgG glycosylation is associated with markers of inflammation and metabolic health.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Karli R Reiding Research Topics

Disease

5	Neoplasms (Cancer) 01/2023 - 01/2016
4	Inflammation (Inflammations) 01/2018 - 01/2016
3	Infections 03/2024 - 01/2018
2	Ulcerative Colitis 10/2023 - 01/2018
2	Crohn Disease (Crohn's Disease) 10/2023 - 01/2018
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2023 - 01/2018
2	Peritonitis 01/2018 - 01/2016
1	Neuralgia (Stump Neuralgia) 01/2023
1	Neuroblastoma 01/2023
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Thyroid Nodule (Nodule, Thyroid) 01/2021
1	Lymphatic Metastasis 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Thyroid Neoplasms (Thyroid Cancer) 01/2021
1	Vasculitis (Vasculitides) 12/2019
1	Type 2 Diabetes Mellitus (MODY) 12/2018
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2018
1	Meningococcal Infections 01/2018
1	Respiratory Syncytial Virus Infections 01/2018
1	Sepsis (Septicemia) 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Rheumatoid Arthritis 01/2017
1	Breast Neoplasms (Breast Cancer) 01/2016

Drug/Important Bio-Agent (IBA)

8	Immunoglobulin G (IgG)IBA 01/2023 - 01/2016
6	Polysaccharides (Glycans)IBA 03/2024 - 01/2018
6	Immunoglobulin A (IgA)IBA 10/2023 - 01/2016
5	AntibodiesIBA 01/2023 - 01/2016
4	Biomarkers (Surrogate Marker)IBA 06/2023 - 01/2017
4	Blood Proteins (Serum Proteins)IBA 12/2018 - 04/2016
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2016
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 03/2024 - 01/2018
1	N-glycolylneuraminic acidIBA 03/2024
1	Membrane Proteins (Integral Membrane Proteins)IBA 03/2024
1	Hemagglutinins (Hemagglutinin)IBA 03/2024
1	FucoseIBA 03/2024
1	EpitopesIBA 03/2024
1	Sialic AcidsIBA 03/2024
1	Fc(alpha) receptorIBA 01/2023
1	dinutuximabIBA 01/2023
1	Myeloblastin (Proteinase 3)IBA 12/2019
1	Peroxidase (Myeloperoxidase)IBA 12/2019
1	GlycopeptidesIBA 01/2018
1	Fc Receptors (Fc Receptor)IBA 01/2018
1	Antiviral Agents (Antivirals)IBA 01/2018
1	Palivizumab FDA Link 01/2018
1	motavizumab (Numax)IBA 01/2018
1	C-Reactive ProteinIBA 01/2017
1	Triglycerides (Triacylglycerol)IBA 01/2017
1	HDL CholesterolIBA 01/2017
1	Mannose (D-Mannose)IBA 01/2017
1	ZymosanIBA 01/2016
1	Trastuzumab (Herceptin)FDA Link 01/2016

Therapy/Procedure

4	Therapeutics 01/2023 - 01/2016
2	Lasers (Laser) 01/2017 - 01/2016
1	Immunotherapy 01/2023
1	Peritoneal Dialysis 01/2018
1	Cyclotrons 01/2017